Clinical Trial Update: VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study [Phase 3]

View source ↗

Summary

Phase 3 trial update for VERU-111 in SARS-CoV infection assessing mortality reduction; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars-cov Infection

Drugs mentioned

• VERU-111 (VERU-111)

Snippet

Sponsor: Veru Inc. | Conditions: SARS-CoV Infection | Phase 3 | Status: COMPLETED | Results posted: 2023-04-18